# Clonidine Inhibits Interictal-like Epileptiform Events in Prefrontal Cortex Pyramidal Neurons

**Authors:** Weronika Kołba, Dominika Herbst, Bartłomiej Szulczyk

PMC · DOI: 10.3390/ijms27062722 · 2026-03-17

## TL;DR

Clonidine, a drug for ADHD, reduces seizure-like activity in prefrontal cortex neurons, possibly by affecting ion channels and NMDA receptors.

## Contribution

This study demonstrates that clonidine inhibits epileptiform events via direct modulation of ionic channels and NMDA receptors.

## Key findings

- Clonidine 100 µM reduced the frequency of interictal-like epileptiform events in prefrontal cortex neurons.
- Clonidine inhibited tonic NMDA receptor currents and fast-inactivating voltage-gated sodium currents.
- The effect of clonidine was not blocked by an alpha-2 adrenergic receptor antagonist, suggesting a direct channel influence.

## Abstract

The mechanism of action of drugs used to treat ADHD has not been fully elucidated. The aim of the study was to assess the effect of clonidine, a drug used to treat ADHD, on interictal-like epileptiform events in prefrontal cortex pyramidal neurons. Epileptiform events (lasting less than 3 s) were recorded in a zero-magnesium and elevated-potassium proepileptic extracellular solution using the patch-clamp methodology. Clonidine 100 µM reduced the frequency of epileptiform events. Moreover, clonidine hyperpolarized the membrane potential recorded in the proepileptic extracellular solution. In the constant presence of the alpha-2 adrenergic receptor antagonist idazoxan 20 µM in all solutions, clonidine 100 µM also inhibited the frequency of interictal-like epileptiform events. This suggests that clonidine inhibited the frequency of interictal events via a direct influence on ionic channels. Furthermore, clonidine inhibited tonic NMDA receptor currents and did not influence tonic AMPA currents. The tested drug inhibited fast-inactivating voltage-gated sodium currents. Blockade of NMDA currents and voltage-gated sodium currents likely contributed to the inhibition of epileptiform events exerted by clonidine. The potential translational relevance of the study is discussed.

## Linked entities

- **Chemicals:** clonidine (PubChem CID 2803), idazoxan (PubChem CID 54459)
- **Diseases:** ADHD (MONDO:0007743)

## Full-text entities

- **Diseases:** ADHD (MESH:D001289), events (MESH:D002318), Epileptiform Events (MESH:D014277)
- **Chemicals:** sodium (MESH:D012964), magnesium (MESH:D008274), Clonidine (MESH:D003000), NMDA (MESH:D016202), potassium (MESH:D011188), idazoxan (MESH:D019329), AMPA (MESH:D018350)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13027239/full.md

---
Source: https://tomesphere.com/paper/PMC13027239